is semaglutide still being compounded Despite FDA ruling, compounded GLP-1s
Description
Research from Nature Metabolism shows that beta-arrestin1, a protein that normally limits the insulin response to GLP-1, does not limit the insulin response to GIP or tirzepatide

Depression and Anxiety , 39, 296-306

If cost, supply shortages or side effects are driving the decision to stop, talking to a prescribing physician about alternatives is an important first step

Monitor for Side Effects : Report any side effects and communicate with your healthcare provider

The side effect profiles are very different because their mechanisms are different

At very low bioavailability, GI effects may be reduced simply because the peptide is not reaching effective concentrations anywhere in the body, including the brain
